Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Hyperrho S/d Mini-dose Generic Name & Formulations
Legal Class
Rx
General Description
Rho(D) immune globulin human; 250 IU; per syringe; soln for IM inj.; preservative-free; latex-free.
Pharmacological Class
Immune globulin.
See Also
How Supplied
Full dose (Single-dose prefilled syringe)—1; Mini dose (Single-dose prefilled syringe)—10
Manufacturer
Hyperrho S/d Mini-dose Indications
Indications
Prevention of isoimmunization of Rho(D) negative women during spontaneous or induced abortion of ≤12 weeks' gestation when mother is not sensitized to Rho(D) antigen and father is not known to be Rho(D) negative.
Hyperrho S/d Mini-dose Dosage and Administration
Adult
Postabortion or miscarriage of up to 12 weeks gestation: 1 syringe IM within 3hrs of spontaneous or induced abortion or within 72hrs following termination of pregnancy.
Children
Not recommended.
Hyperrho S/d Mini-dose Contraindications
Contraindications
Neonates.
Hyperrho S/d Mini-dose Boxed Warnings
Not Applicable
Hyperrho S/d Mini-dose Warnings/Precautions
Warnings/Precautions
Contains human plasma; monitor for possible infection transmission. IgA deficiency. Pregnancy (Cat.C).
Hyperrho S/d Mini-dose Pharmacokinetics
See Literature
Hyperrho S/d Mini-dose Interactions
Interactions
Avoid live vaccines within 3 months.
Hyperrho S/d Mini-dose Adverse Reactions
Adverse Reactions
Local or infusion reactions.
Hyperrho S/d Mini-dose Clinical Trials
See Literature
Hyperrho S/d Mini-dose Note
Notes
Report all infections suspected to be transmitted by HyperRHO S/D to (800) 520-2807.
Hyperrho S/d Mini-dose Patient Counseling
See Literature
